Jacob Jacobsen

4.2k total citations · 2 hit papers
77 papers, 3.3k citations indexed

About

Jacob Jacobsen is a scholar working on Oncology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jacob Jacobsen has authored 77 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 26 papers in Surgery and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jacob Jacobsen's work include Diabetes Treatment and Management (12 papers), Bone health and treatments (10 papers) and Cancer Diagnosis and Treatment (10 papers). Jacob Jacobsen is often cited by papers focused on Diabetes Treatment and Management (12 papers), Bone health and treatments (10 papers) and Cancer Diagnosis and Treatment (10 papers). Jacob Jacobsen collaborates with scholars based in Denmark, United States and Germany. Jacob Jacobsen's co-authors include Henrik Toft Sørensen, Mette Nørgaard, Morten Schmidt, Hans Erik Bøtker, Annette Østergaard Jensen, T. L. Lash, Jon P. Fryzek, Søren Paaske Johnsen, Lars Pedersen and Mellissa Yong and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Jacob Jacobsen

75 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study

2012 361 citations Morten Schmidt, Jacob Jacobsen et al. BMJ profile →
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea

2019 302 citations Jacob Jacobsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob Jacobsen Denmark	32	1.0k	917	745	683	546	77	3.3k
Federico Rea Italy	39	1.0k 1.0×	833 0.9×	514 0.7×	1.8k 2.7×	472 0.9×	237	5.4k
Paul Cockwell United Kingdom	46	874 0.9×	933 1.0×	461 0.6×	1.1k 1.6×	2.1k 3.9×	189	6.9k
Neil Blumberg United States	49	699 0.7×	1.4k 1.5×	265 0.4×	631 0.9×	452 0.8×	193	7.3k
Bryan N. Becker United States	44	332 0.3×	1.8k 2.0×	411 0.6×	812 1.2×	453 0.8×	120	5.5k
Patrik Finne Finland	39	482 0.5×	592 0.6×	422 0.6×	999 1.5×	678 1.2×	131	3.8k
Changhong Yu United States	33	539 0.5×	760 0.8×	431 0.6×	1.6k 2.3×	351 0.6×	99	3.3k
Angelo Vanzulli Italy	34	614 0.6×	913 1.0×	249 0.3×	914 1.3×	391 0.7×	172	4.1k
Christian Morath Germany	37	400 0.4×	1.3k 1.4×	213 0.3×	588 0.9×	570 1.0×	220	4.8k
Brian Shine United Kingdom	33	309 0.3×	927 1.0×	1.2k 1.7×	556 0.8×	286 0.5×	127	3.8k
Maria Grazia Valsecchi Italy	49	870 0.9×	626 0.7×	206 0.3×	472 0.7×	959 1.8×	246	7.7k

Countries citing papers authored by Jacob Jacobsen

Since Specialization

Citations

This map shows the geographic impact of Jacob Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Jacobsen more than expected).

Fields of papers citing papers by Jacob Jacobsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Jacobsen. The network helps show where Jacob Jacobsen may publish in the future.

Co-authorship network of co-authors of Jacob Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Jacobsen. A scholar is included among the top collaborators of Jacob Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Jacobsen. Jacob Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heise, Tim, Ulrike Hövelmann, Eric Zijlstra, et al.. (2016). A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus. Drugs & Aging. 34(1). 29–38. 31 indexed citations

Heise, Tim, Kirstine L. Stender-Petersen, Ulrike Hövelmann, et al.. (2016). Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus. Clinical Pharmacokinetics. 56(6). 649–660. 51 indexed citations

Nørgaard, Mette, et al.. (2015). Patient comorbidity is associated with conservative treatment of localized prostate cancer. Scandinavian Journal of Urology. 49(5). 366–370. 7 indexed citations

Cetin, Karynsa, Christian Fynbo Christiansen, Jacob Jacobsen, Mette Nørgaard, & Henrik Toft Sørensen. (2014). Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study. Lung Cancer. 86(2). 247–254. 105 indexed citations

Troisi, Rebecca, Olof Stephansson, Jacob Jacobsen, et al.. (2013). Perinatal characteristics and bone cancer risk in offspring – a Scandinavian population-based study. Acta Oncologica. 53(6). 830–838. 6 indexed citations

Schmidt, Morten, Jacob Jacobsen, T. L. Lash, Hans Erik Bøtker, & Henrik Toft Sørensen. (2012). 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 344(jan25 2). e356–e356. 361 indexed citations breakdown →

Troisi, Rebecca, Tom Grotmol, Jacob Jacobsen, et al.. (2012). Perinatal characteristics and breast cancer risk in daughters: a Scandinavian population-based study. Journal of Developmental Origins of Health and Disease. 4(1). 35–41. 14 indexed citations

Jacobsen, Jacob, et al.. (2011). Toward a New Understanding of Crises:Defining Organizational Crises Through a Phenomenological Approach. 1 indexed citations

Yong, Mellissa, Annette Østergaard Jensen, Jacob Jacobsen, et al.. (2011). Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007). Breast Cancer Research and Treatment. 129(2). 495–503. 138 indexed citations

10.

Thomsen, Reimar W., W. Marieke Schoonen, Dóra Körmendiné Farkas, et al.. (2009). Risk for Hospital Contact With Infection in Patients With Splenectomy. Annals of Internal Medicine. 7 indexed citations

11.

Horsdal, Henriette Thisted, Søren Paaske Johnsen, Flemming L. Søndergaard, et al.. (2009). Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population‐based follow‐up study. Diabetes/Metabolism Research and Reviews. 25(6). 515–522. 33 indexed citations

12.

Lund, Lars Christian, Jacob Jacobsen, Peter E. Clark, Michael Borre, & Mette Nørgaard. (2009). Impact of Comorbidity on Survival of Invasive Bladder Cancer Patients, 1996-2007: A Danish Population-based Cohort Study. Urology. 75(2). 393–398. 29 indexed citations

13.

Tetsche, Mette S, Mette Nørgaard, Jacob Jacobsen, Pia Wogelius, & Henrik Toft Sørensen. (2007). Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study. International Journal of Gynecological Cancer. 18(3). 421–427. 38 indexed citations

14.

Gasse, Christiane, Jacob Jacobsen, Anders Christian Larsen, et al.. (2007). Secondary Medical Prevention among Danish Patients Hospitalised with Either Peripheral Arterial Disease or Myocardial Infarction. European Journal of Vascular and Endovascular Surgery. 35(1). 51–58. 36 indexed citations

15.

Nørgaard, Mette, Jacob Jacobsen, Christiane Gasse, et al.. (2007). Selective Serotonin Reuptake Inhibitors and Risk of Acute Pancreatitis. Journal of Clinical Psychopharmacology. 27(3). 259–262. 17 indexed citations

16.

Thomsen, Reimar W., Anders H. Riis, Mette Nørgaard, et al.. (2006). Rising incidence and persistently high mortality of hospitalized pneumonia: 10-year population-based study in Denmark. Journal of Internal Medicine. 259. 3 indexed citations

17.

Thomsen, Reimar W., Anders H. Riis, Mette Nørgaard, et al.. (2006). Rising incidence and persistently high mortality of hospitalized pneumonia: a 10‐year population‐based study in Denmark. Journal of Internal Medicine. 259(4). 410–417. 129 indexed citations

18.

Nørgaard, Mette, et al.. (2005). Metronidazole and risk of acute pancreatitis: a population‐based case–control study. Alimentary Pharmacology & Therapeutics. 21(4). 415–420. 20 indexed citations

19.

Jacobsen, Jacob, Estrid Muff Munk, S. Friis, et al.. (2005). Statins and the risk of acute pancreatitis: a population‐based case–control study. Alimentary Pharmacology & Therapeutics. 23(1). 185–190. 36 indexed citations

20.

Tamás, Gy., Michel Marre, R. Astorga, et al.. (2001). Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diabetes Research and Clinical Practice. 54(2). 105–114. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact